Lemonade, Inc.
$5.12B- Market cap
- $4.13B
- Debt
- +$1.39B
- Cash
- −$399.10M
Capital structure 75% equity / 25% debt · EV / Revenue 6.94x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $4.13B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: LMND stock price at premium vs TDOC $53.41 current versus $4.30 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TDOC's multiple
Implied fair value · at LMND's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: LMND FY 2025 (ended Dec 31, 2025) · TDOC FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 75% equity / 25% debt · EV / Revenue 6.94x
Capital structure 52% equity / 48% debt · EV / Revenue 0.55x · EV / EBITDA 4.74x
LMND carries the larger enterprise value at $5.12B against $1.40B; TDOC trades on the lower EV / Revenue multiple (0.55x vs 6.94x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Lemonade, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
TELADOC HEALTH, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
2.60x
0.75x
Net debt / EBITDA
Leverage against operating earnings
-7.63x
0.87x
Cash and equivalents
Liquid reserves on the balance sheet
$399.10M
$781.08M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Root, Inc.
LMND vs ROOT
Hippo Holdings Inc.
LMND vs HIPO
RLI CORP
LMND vs RLI
AMERICAN FINANCIAL GROUP INC
LMND vs AFG
CINCINNATI FINANCIAL CORP
LMND vs CINF
Hims & Hers Health, Inc.
LMND vs HIMS
GoodRx Holdings, Inc.
LMND vs GDRX
Cigna Group
LMND vs CI
VEEVA SYSTEMS INC
LMND vs VEEV
$1.39B
$1.04B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.